Treatment of Diarrhea-Predominant IBS

First-Line Pharmacological Management

The American Gastroenterological Association recommends loperamide as the primary agent for managing diarrhea and urgency in IBS-D, with proven efficacy at doses of 4-12 mg daily 1
Loperamide slows small and large intestinal transit, reduces stool frequency by 36%, improves stool consistency by 32%, and reduces urgency, according to the American Gastroenterological Association 1
Antispasmodics are first-line for pain management, with anticholinergic agents showing slightly better efficacy than direct smooth muscle relaxants, though anticholinergics cause more dry mouth, as recommended by the European Society of Gastrointestinal Motility 1, 4
Meta-analysis shows antispasmodics provide 64% improvement versus 45% on placebo, though evidence quality is rated as very low, according to the American College of Gastroenterology 1, 4

The American College of Gastroenterology recommends escalating to tricyclic antidepressants if symptoms persist after 3-6 weeks of first-line therapy, which are currently the most effective drugs for treating IBS 1, 2, 3
Start amitriptyline at 10 mg once daily at bedtime, titrate over 3 weeks to 30 mg once daily, based on response and tolerability, as recommended by the American Gastroenterological Association 2, 3
TCAs work through central neuromodulation, modify gut motility, and alter visceral nerve responses, according to the European Society of Gastrointestinal Motility 1, 2

Approximately 10% of IBS-D patients have bile salt malabsorption and may respond to cholestyramine, which should be considered in patients with persistent diarrhea despite standard therapy, as recommended by the American Gastroenterological Association 1
Regular exercise is strongly recommended for all IBS patients at the initial visit, and identify and eliminate dietary triggers including lactose, fructose, caffeine, and alcohol, according to the American College of Gastroenterology 2, 3
Soluble fiber starting at 3-4 g/day can help global symptoms, though avoid insoluble fiber which worsens symptoms, as recommended by the European Society of Gastrointestinal Motility 2, 3
Low FODMAP diet is second-line dietary therapy if symptoms persist, supervised by a trained dietitian with planned reintroduction, according to the American Gastroenterological Association 2, 3

Never use opioids for chronic pain management in IBS-D due to dependency risk and lack of efficacy, as recommended by the American College of Gastroenterology 2
Avoid treating loperamide as the sole therapy when abdominal pain is prominent; combine with antispasmodics or TCAs, according to the American Gastroenterological Association 1, 3
Avoid TCAs if constipation is a major feature, as they worsen constipation, as recommended by the European Society of Gastrointestinal Motility 1